Y Intercept Hong Kong Ltd Acquires 57,594 Shares of Ardent Health, Inc. $ARDT

Y Intercept Hong Kong Ltd grew its stake in shares of Ardent Health, Inc. (NYSE:ARDT) by 558.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,910 shares of the company’s stock after buying an additional 57,594 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Ardent Health were worth $928,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. CWM LLC grew its stake in Ardent Health by 990.6% during the second quarter. CWM LLC now owns 2,203 shares of the company’s stock valued at $30,000 after acquiring an additional 2,001 shares in the last quarter. Morse Asset Management Inc purchased a new position in Ardent Health during the first quarter valued at approximately $36,000. Quarry LP grew its stake in Ardent Health by 1,519.4% during the first quarter. Quarry LP now owns 5,020 shares of the company’s stock valued at $69,000 after acquiring an additional 4,710 shares in the last quarter. Deutsche Bank AG grew its stake in Ardent Health by 140.1% during the first quarter. Deutsche Bank AG now owns 6,882 shares of the company’s stock valued at $95,000 after acquiring an additional 4,016 shares in the last quarter. Finally, Corebridge Financial Inc. grew its stake in Ardent Health by 91.6% during the first quarter. Corebridge Financial Inc. now owns 11,687 shares of the company’s stock valued at $161,000 after acquiring an additional 5,586 shares in the last quarter.

Ardent Health Price Performance

Shares of Ardent Health stock opened at $14.59 on Wednesday. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The company has a market cap of $2.09 billion, a PE ratio of 8.06, a P/E/G ratio of 6.49 and a beta of 0.44. The business has a 50 day moving average of $13.77 and a 200 day moving average of $13.31. Ardent Health, Inc. has a 52 week low of $10.10 and a 52 week high of $18.19.

Ardent Health (NYSE:ARDT) last announced its earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%.The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. As a group, equities research analysts forecast that Ardent Health, Inc. will post 1.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ARDT. JPMorgan Chase & Co. lowered their target price on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating on the stock in a research note on Monday, August 11th. UBS Group began coverage on shares of Ardent Health in a research note on Wednesday, September 10th. They issued a “buy” rating and a $17.00 target price on the stock. Wall Street Zen raised shares of Ardent Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. KeyCorp lowered their target price on shares of Ardent Health from $24.00 to $20.00 and set an “overweight” rating on the stock in a research note on Thursday, August 7th. Finally, Bank of America downgraded shares of Ardent Health from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $15.50 to $14.60 in a research note on Wednesday, July 16th. Nine investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $19.30.

Ardent Health Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.